Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108251-108300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03709758
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
PHASE1Recruiting
64 participants
Started: Oct 17, 2018 · Completed: Jun 1, 2026
1 condition3 sponsors2 locations
NCT03710902
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
NARecruiting
405 participants
Started: Oct 17, 2018 · Completed: Sep 30, 2028
5 conditions1 sponsor4 locations
NCT03646461
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
PHASE2Active, not recruiting
5 participants
Started: Oct 17, 2018 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT03598608
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)
PHASE1/PHASE2Active, not recruiting
174 participants
Started: Oct 17, 2018 · Completed: Jan 16, 2026
3 conditions1 sponsor25 locations
NCT03677843
Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline
N/ARecruiting
100 participants
Started: Oct 16, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT02797457
Medical Economic Evaluation of Bilateral Allograft of Hands and Forearms
NARecruiting
40 participants
Started: Oct 16, 2018 · Completed: Oct 16, 2031
1 condition1 sponsor11 locations
NCT03957434
Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence
NAActive, not recruiting
44 participants
Started: Oct 16, 2018 · Completed: Oct 16, 2025
2 conditions5 sponsors1 location
NCT03561051
The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
N/AActive, not recruiting
700 participants
Started: Oct 16, 2018 · Completed: Jan 1, 2025
3 conditions5 sponsors13 locations
NCT03655015
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
N/ARecruiting
150 participants
Started: Oct 16, 2018 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT03685110
CoreHip - Post Market Clinical Follow-Up Study
N/AActive, not recruiting
248 participants
Started: Oct 16, 2018 · Completed: Dec 31, 2028
4 conditions1 sponsor6 locations
NCT04390906
A Study of Cognitive Changes in Patients Receiving Brain Radiation
N/AActive, not recruiting
75 participants
Started: Oct 16, 2018 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT05170854
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
N/AActive, not recruiting
4,774,035 participants
Started: Oct 16, 2018 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT03670680
Efficiency of Lina LibrataTM System
NAActive, not recruiting
38 participants
Started: Oct 16, 2018 · Completed: Oct 16, 2025
1 condition1 sponsor1 location
NCT03488693
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
PHASE3Recruiting
2,140 participants
Started: Oct 16, 2018 · Completed: Dec 30, 2027
1 condition5 sponsors464 locations
NCT03982485
Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer
PHASE2Active, not recruiting
196 participants
Started: Oct 16, 2018 · Completed: Mar 29, 2031
1 condition1 sponsor1 location
NCT03602092
Observational Registry Data on GIST Patients
N/ARecruiting
3,000 participants
Started: Oct 16, 2018 · Completed: Dec 31, 2025
1 condition9 sponsors1 location
NCT06400238
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)
PHASE2Active, not recruiting
35 participants
Started: Oct 15, 2018 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT03500458
Impact of Sleep Extension in Adolescents
NAActive, not recruiting
75 participants
Started: Oct 15, 2018 · Completed: May 31, 2025
3 conditions2 sponsors1 location
NCT03655223
Early Check: Expanded Screening in Newborns
N/AEnrolling by invitation
30,000 participants
Started: Oct 15, 2018 · Completed: Dec 31, 2025
185 conditions18 sponsors1 location
NCT03471247
CYCLE: A Randomized Clinical Trial of Early In-bed Cycling for Mechanically Ventilated Patients
NAActive, not recruiting
360 participants
Started: Oct 15, 2018 · Completed: Aug 31, 2024
4 conditions4 sponsors16 locations
NCT03364296
Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
NARecruiting
930 participants
Started: Oct 15, 2018 · Completed: Mar 1, 2025
1 condition1 sponsor5 locations
NCT03635021
Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer
PHASE3Active, not recruiting
419 participants
Started: Oct 15, 2018 · Completed: Jun 28, 2025
1 condition2 sponsors1 location
NCT03708822
Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
PHASE2Active, not recruiting
48 participants
Started: Oct 15, 2018 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT03697707
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
PHASE2Active, not recruiting
20 participants
Started: Oct 15, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors10 locations
NCT03964480
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
N/ARecruiting
1,000 participants
Started: Oct 14, 2018 · Completed: Jul 30, 2025
1 condition1 sponsor6 locations
NCT02359253
Robot Aided Rehabilitation - Intervention
NARecruiting
72 participants
Started: Oct 14, 2018 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04016870
Project My Heart Your Heart: Pacemaker Reuse
NAActive, not recruiting
370 participants
Started: Oct 13, 2018 · Completed: Jan 31, 2026
3 conditions1 sponsor8 locations
NCT03587311
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2Active, not recruiting
96 participants
Started: Oct 12, 2018 · Completed: Oct 21, 2026
8 conditions1 sponsor23 locations
NCT03712774
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
N/ARecruiting
60 participants
Started: Oct 12, 2018 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06350734
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
N/ARecruiting
704 participants
Started: Oct 12, 2018 · Completed: Jan 31, 2029
5 conditions1 sponsor3 locations
NCT03777384
EValuating the Safety of De-escaLated Head and Neck Irradiation in HPV PositivE Oropharynx Cancer in Non-smokers/minimal Smokers
N/AActive, not recruiting
75 participants
Started: Oct 12, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT03464344
Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.
NARecruiting
170 participants
Started: Oct 12, 2018 · Completed: Feb 28, 2025
1 condition1 sponsor4 locations
NCT03716089
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
N/ARecruiting
250 participants
Started: Oct 11, 2018 · Completed: Apr 1, 2027
4 conditions1 sponsor1 location
NCT03264131
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
PHASE2Active, not recruiting
16 participants
Started: Oct 11, 2018 · Completed: Dec 15, 2028
3 conditions2 sponsors4 locations
NCT03550911
Biological Collection From Samples From The Gut Microbiota In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine (CARBAMICROBIOTA)
N/ARecruiting
26 participants
Started: Oct 11, 2018 · Completed: Oct 11, 2025
2 conditions1 sponsor1 location
NCT03729518
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
NAActive, not recruiting
150 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04714866
Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD)
NAActive, not recruiting
65 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03997162
Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery
N/AActive, not recruiting
52 participants
Started: Oct 11, 2018 · Completed: Feb 4, 2026
18 conditions2 sponsors1 location
NCT03689699
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
PHASE1/PHASE2Active, not recruiting
59 participants
Started: Oct 11, 2018 · Completed: Jan 31, 2026
2 conditions2 sponsors4 locations
NCT03759431
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
PHASE2Active, not recruiting
155 participants
Started: Oct 11, 2018 · Completed: Dec 12, 2026
3 conditions3 sponsors3 locations
NCT03679650
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
PHASE1Recruiting
45 participants
Started: Oct 11, 2018 · Completed: Aug 31, 2026
1 condition3 sponsors2 locations
NCT03412760
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
NAEnrolling by invitation
500 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2025
3 conditions4 sponsors1 location
NCT06190600
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
NAActive, not recruiting
40 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04081428
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
N/AActive, not recruiting
60 participants
Started: Oct 11, 2018 · Completed: Jan 11, 2026
4 conditions1 sponsor1 location
NCT03602859
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
PHASE3Active, not recruiting
1,402 participants
Started: Oct 11, 2018 · Completed: Jun 22, 2026
2 conditions2 sponsors180 locations
NCT03630991
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
PHASE1Recruiting
58 participants
Started: Oct 11, 2018 · Completed: Apr 30, 2027
18 conditions1 sponsor1 location
NCT03624673
Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell Carcinoma
NAActive, not recruiting
380 participants
Started: Oct 11, 2018 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03249207
SC IL-1Ra in SAH - Phase III Trial (SCIL)
PHASE3Active, not recruiting
612 participants
Started: Oct 11, 2018 · Completed: Sep 30, 2024
1 condition4 sponsors17 locations
NCT03685721
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
N/ARecruiting
800 participants
Started: Oct 11, 2018 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT03616587
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
PHASE1Active, not recruiting
396 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor17 locations